Daina Tagavi

My work focuses on the development, dissemination, and implementation of tools for the assessment and treatment of autism spectrum disorder. I am also interested in transdiagnostic interventions for autism spectrum disorder to increase efficacy for individuals and families, as well as access to care. My clinical pursuits include conducting diagnostic evaluations for autism for youth of all ages, as well as running groups and classes for autistic individuals and their families.

Karís Casagrande

Karís Casagrande (she/they), PhD, is a clinical psychologist and director of community outreach at Seattle Children’s Autism Center. She completed her postdoctoral fellowship at University of Washington and Seattle Children’s Hospital, and is an alum of the Leadership Education in Neurodevelopmental and Related Disabilities (LEND) program. Clinically, she specializes in neurodevelopmental assessment, parent coaching models of intervention focused on behavior and social communication, and cognitive-behavioral therapy for individuals with neurodevelopmental differences. She is engaged in community outreach and capacity-building research and programming to improve access to and quality of care for individuals with autism and their families in their home communities. Previously, she was the president of a community non-profit advocacy group and worked with community organizations such as museums, theaters, and hotels to increase accessibility and inclusion for individuals with sensory and developmental differences. She is excited to continue engaging communities and improving accessibility in this new role at the Autism Center. 

Sheena Friesen

Sheena Friesen, PhD (she/her), is the attending psychologist for the Child Program on the inpatient Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. She has clinical expertise in disruptive behavior disorders, comprehensive assessment, Dialectical Behavior Therapy, Exposure Therapies, Parent Training, and Trauma-Focused Cognitive Behavioral Therapy.

Dr. Friesen’s research interests broadly focus on advancing knowledge of least restrictive interventions in acute and complex care contexts, trauma-informed care, and interventions designed to address children’s disruptive behavior problems. She has collaborated on and co-led efforts to design and implement a multi-tiered, Modified Positive Behavioral Interventions and Supports (M-PBIS) model of care aimed at increasing positive behavior interventions, reducing restraint and PRN use, and ameliorating racial gaps in care delivery. 

Dr. Friesen received her Ph.D. in School Psychology from the University of Washington in Seattle, WA. She completed her pre-doctoral internship training at Johns Hopkins School of Medicine and Kennedy Krieger Institute and went on to complete her postdoctoral fellowship in acute care and clinical psychology at Seattle Children’s Hospital.

Daniel W. Fisher

My clinical and research interests center around behavioral and psychological symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits.

Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.

Margaret Z. Wang

I am a practicing psychiatrist and health services researcher whose research has focused on system-level strategies to deliver high-quality care in settings with few clinical resources or available specialists. I am board certified in general adult psychiatry and geriatric psychiatry and my clinical work has included provision of psychiatric outpatient, inpatient, and emergency services care. I am interested in leveraging existing community infrastructure and adapting evidence based clinical practices to suit community contexts to reduce treatment gaps.

Jacqueline Hobbs

I recently joined the faculty at UW and am the new program director for the general residency program. I am excited to be here! I have been working in graduate medical education and have been a program director for over 14 years. Although my major focus is graduate medical education, I am also passionate about patient safety, quality improvement, and healthcare risk management. Additionally, I have a background in basic research with expertise in virology, microbiology, and immunology.

Sarah Danzo

My research broadly aims to better understand the etiology of depression and risk behaviors such as suicide and substance use across development, and translate findings to inform prevention and intervention strategies for youth and families.  My work focuses on partnering with communities and primary care clinics to improve access to and use of effective mental health services.

My current projects include studies focused on adapting and evaluating suicide prevention intervention and implementation strategies for use with adolescents and their families in primary care and outpatient medical settings, including developing and adapting brief, just-in-time, and digital interventions to expand access to services.

In addition to research, I am also a clinical psychologist in the Mood and Anxiety Disorders Program and the Crisis Care Clinic at Seattle Children’s Hospital.

Connor Gallik

Dr. Connor Gallik, PhD, is the attending psychologist for the Adolescent Program on the Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at University of Washington.

Prior to joining the staff and faculty at Seattle Children’s/UW, Dr. Gallik completed his graduate education at the University of Connecticut with an emphasis in child and adolescent clinical psychology. He completed his clinical internship at Pacific University’s Psychology and Comprehensive Health Clinic and went on to complete a postdoctoral fellowship in clinical psychology at Seattle Children’s Hospital with an emphasis in DBT and inpatient care.

His research focuses on understanding factors related to the mental health and wellbeing of transgender and gender diverse (TGD) TGD youth and evidence-based practice on inpatient units. Clinically, he is interested in working with children, adolescents, and their families, with a focus on TGD youth. Dr. Gallik also provides training in TGD affirming care for mental health and medical professionals and speaks to community audiences about supporting transgender youth.

Tessa Frohe

I am a trained Behavioral Scientist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health.​ My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.